CN101374857A - 新的t辅助细胞抗原决定簇（thd）肽 - Google Patents

新的t辅助细胞抗原决定簇（thd）肽 Download PDF

Info

Publication number
CN101374857A
CN101374857A CNA2006800486390A CN200680048639A CN101374857A CN 101374857 A CN101374857 A CN 101374857A CN A2006800486390 A CNA2006800486390 A CN A2006800486390A CN 200680048639 A CN200680048639 A CN 200680048639A CN 101374857 A CN101374857 A CN 101374857A
Authority
CN
China
Prior art keywords
hla
seq
peptide
arg
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800486390A
Other languages
English (en)
Chinese (zh)
Inventor
F·博拉斯库斯塔
J·J·拉萨特萨加斯蒂贝尔扎
M·鲁茨埃戈兹库
P·萨罗比尤加里扎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proyecto de Biomedicina CIMA SL
Original Assignee
Proyecto de Biomedicina CIMA SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proyecto de Biomedicina CIMA SL filed Critical Proyecto de Biomedicina CIMA SL
Publication of CN101374857A publication Critical patent/CN101374857A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA2006800486390A 2005-12-23 2006-12-19 新的t辅助细胞抗原决定簇（thd）肽 Pending CN101374857A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200503169 2005-12-23
ES200503169A ES2310072B1 (es) 2005-12-23 2005-12-23 Nuevos peptidos determinantes antigenicos t colaboradores (/dth).

Publications (1)

Publication Number Publication Date
CN101374857A true CN101374857A (zh) 2009-02-25

Family

ID=38217710

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800486390A Pending CN101374857A (zh) 2005-12-23 2006-12-19 新的t辅助细胞抗原决定簇（thd）肽

Country Status (12)

Country Link
US (1) US20090220533A1 (enExample)
EP (1) EP1978026B1 (enExample)
JP (1) JP2009520772A (enExample)
CN (1) CN101374857A (enExample)
AT (1) ATE502047T1 (enExample)
AU (1) AU2006329789A1 (enExample)
BR (1) BRPI0620243A2 (enExample)
CA (1) CA2634840A1 (enExample)
DE (1) DE602006020781D1 (enExample)
ES (1) ES2310072B1 (enExample)
RU (1) RU2008129731A (enExample)
WO (1) WO2007074188A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2411049B1 (en) 2009-03-27 2020-01-15 Academia Sinica Methods and compositions for immunization against virus
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT735893E (pt) * 1993-09-14 2009-03-06 Pharmexa Inc Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária
BR9710404A (pt) 1996-01-24 1999-08-17 Epimmune Inc Indu-Æo de resposta imune contra determinantes desejados
US6413517B1 (en) * 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
EP1080370A4 (en) * 1998-05-29 2003-07-30 Epimmune Inc IDENTIFICATION OF RESILIENT DR EPITOPES LARGELY REACTIVE
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
US20040236514A1 (en) * 2001-12-13 2004-11-25 Lee Stephen C. Controlling distribution of epitopes in polypeptide sequences

Also Published As

Publication number Publication date
AU2006329789A1 (en) 2007-07-05
EP1978026A4 (en) 2010-03-10
CA2634840A1 (en) 2007-07-05
RU2008129731A (ru) 2010-01-27
ES2310072B1 (es) 2009-11-16
DE602006020781D1 (en) 2011-04-28
BRPI0620243A2 (pt) 2011-11-08
ES2310072A1 (es) 2008-12-16
EP1978026B1 (en) 2011-03-16
WO2007074188A1 (es) 2007-07-05
US20090220533A1 (en) 2009-09-03
EP1978026A1 (en) 2008-10-08
ATE502047T1 (de) 2011-04-15
JP2009520772A (ja) 2009-05-28

Similar Documents

Publication Publication Date Title
AU2020230295B2 (en) Formulations for neoplasia vaccines
CN107148427B (zh) 新型免疫原性肽
RU2721574C2 (ru) Вакцинная композиция против злокачественной опухоли
CA2950863C (en) Synthetic long peptides (slp) for therapeutic vaccination against hepatitis b virus infection
RU2761653C2 (ru) Пептиды и способы для лечения диабета
JP2021514178A (ja) 異なるタイプのがんに対する免疫療法で使用するための非標準起源のペプチドおよびペプチド組み合わせ
KR20210093933A (ko) 개선된 산화환원 효소 모티프를 갖는 면역원성 펩티드
JP7026970B2 (ja) 白血病およびその他のがんに対する免疫療法において使用するためのペプチドおよびペプチドの組み合わせ
JP2002506003A (ja) インターフェロン−γフラグメントを含むリポペプチド、及び薬学的組成物におけるその使用
JP2025160241A (ja) ポリオーマウイルスのための免疫療法
JP2025158982A (ja) 糖尿病患者を階層化する方法
CN101330928B (zh) 用于预防和治疗丙型肝炎的免疫刺激剂组合
CN101374857A (zh) 新的t辅助细胞抗原决定簇（thd）肽
CA3257626A1 (en) Viral Peptides and Their Uses
KR20240015672A (ko) 면역원성 펩티드를 사용한 개선된 치료 방법
JP2021045150A (ja) Ａｍｌおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ
MX2008008036A (en) Novel t-helper antigenic determinant (thd) peptides
CA3235174A1 (en) Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of diseases caused by sars-cov-2

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090225